Condition
Atrial Functional Mitral Regurgitation clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Atrial Functional Mitral Regurgitation clinical trials that are recruiting, at sites in 7 countries (most in Canada (2), China (2), France (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest Atrial Functional Mitral Regurgitation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Valsartan for Atrial Functional Mitral Regurgitation (AFMR) — Pilot | Phase 2/3 | Québec, Quebec | Recruiting | Apr 20, 2026 |
| Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation | — | Beijing, Beijing Municipality | Recruiting | Feb 17, 2026 |
| Evaluating a procedure for treating atrial functional mitral regurgitation | — | The Bronx, New York and 21 other locations | Recruiting | Apr 4, 2025 |
| Catheter ablation for people with persistent atrial fibrillation and severe atrial functional mitral regurgitation | — | Hefei, Anhui and 16 other locations | Recruiting | Mar 19, 2025 |
All recruiting trials (4)
-
Valsartan for Atrial Functional Mitral Regurgitation (AFMR) — Pilot
Atrial functional mitral regurgitation is studied to see if valsartan can slow its progression in adults with good heart pump function.
-
Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
This trial tests whether a transcatheter edge-to-edge repair device helps people with atrial functional mitral regurgitation who still have symptoms despite standard therapy.
-
Evaluating a procedure for treating atrial functional mitral regurgitation
This study looks at how well a new heart procedure works for people with atrial functional mitral regurgitation to see if it helps improve their health.
-
Catheter ablation for people with persistent atrial fibrillation and severe atrial functional mitral regurgitation
This will test whether adding catheter ablation to usual medicines helps adults with persistent atrial fibrillation and moderate-to-severe or severe atrial functional mitral regurgitation reduce valve leakage and improve symptoms and outcomes.
Related topics
Quick answers
How many Atrial Functional Mitral Regurgitation clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Canada (2 trials), China (2 trials), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.